CID 118480924

Luxeptinib

Structural Information

Molecular Formula
C25H17F4N5O2
SMILES
CC1=CN=C(N1)C2=C3C(=C(C=C2)C4=C(C=C(C=C4)NC(=O)NC5=C(C=C(C=C5F)F)F)F)CNC3=O
InChI
InChI=1S/C25H17F4N5O2/c1-11-9-30-23(32-11)16-5-4-14(17-10-31-24(35)21(16)17)15-3-2-13(8-18(15)27)33-25(36)34-22-19(28)6-12(26)7-20(22)29/h2-9H,10H2,1H3,(H,30,32)(H,31,35)(H2,33,34,36)
InChIKey
MWHHJYUHCZWSLS-UHFFFAOYSA-N
Compound name
1-[3-fluoro-4-[7-(5-methyl-1H-imidazol-2-yl)-1-oxo-2,3-dihydroisoindol-4-yl]phenyl]-3-(2,4,6-trifluorophenyl)urea
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

1
References

1310
Patents

495.13184 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 496.13912 210.8
[M+Na]+ 518.12106 219.0
[M+NH4]+ 513.16566 212.5
[M+K]+ 534.09500 216.7
[M-H]- 494.12456 210.4
[M+Na-2H]- 516.10651 213.5
[M]+ 495.13129 211.2
[M]- 495.13239 211.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe